Winda, a Stage IV ovarian cancer patient from Jakarta, Indonesia, was diagnosed with a 9cm tumor in her left ovary in June 2016. She underwent tumor resection surgery, but by December 2016, she began experiencing abdominal pain and physical discomfort again. Subsequent examinations revealed a 1.4 cm tumor in her pelvic lymph nodes. In January 2017, she was diagnosed with recurrent left ovarian cancer (stage IV) with mediastinal and subclavian lymph node metastases.

When Winda arrived at Guangzhou Modern Cancer Hospital, she was extremely weak. The hospital’s MDT team developed a treatment plan combining minimally invasive interventional therapy and natural therapy, avoiding uterus removal and preserving ovarian function. After three sessions of interventional therapy, the pelvic lymph node tumor completely disappeared. Following doctors’ advice, she adopted healthy dietary and exercise habits and later gave birth to a healthy, adorable baby.

In 2023, Ms. Beh, a 30-year-old woman, began experiencing frequent abdominal bloating and was diagnosed with ovarian cancer. Determined to act quickly, she underwent surgery in Malaysia to remove her left fallopian tube and ovary, followed by six rounds of systemic chemotherapy. By June 2024, she developed rectal bleeding, and a colonoscopy revealed cancer spread to the rectum (an 8 cm lesion near the anus), cystic lesions in her remaining right ovary, and metastases to pelvic lymph nodes and both lungs. Local doctors advised removing all ovarian tissue, which would render her infertile.

On August 2, 2024, Ms. Beh and her mother sought treatment at Guangzhou Modern Cancer Hospital. The MDT team promptly designed an interventional therapy plan. After the second session, a CT scan showed significant shrinkage of the right ovarian lesion and cervical mass, with smaller lesions and pelvic lymph node metastases vanishing entirely. Her remaining ovary was preserved.

Nowiti, from Indonesia, was diagnosed with ovarian cancer in 2019 and underwent a hysterectomy and bilateral oophorectomy at a local hospital. Despite postoperative chemotherapy, the cancer metastasized to multiple sites, and it locally recurred in 2023. Upon a friend’s recommendation, she came to Guangzhou Modern Cancer Hospital for minimally invasive treatment.

After two sessions of interventional therapy, Nowiti reported complete resolution of her symptoms. CT scans showed remarkable treatment efficacy, with tumors nearly undetectable. By March 2024, her tumor markers had normalized, and all lesions had completely disappeared.